Equity Details
Price & Market Data
Price: $0.0161
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $2,053,858
Daily Volume: 0
Performance Metrics
1 Week: 46.36%
1 Month: 27.78%
3 Months: 11.03%
6 Months: -8.26%
1 Year: -22.60%
YTD: -5.85%
About Appili Therapeutics Inc. (APLIF)
Detailed report on Appili Therapeutics Inc. (APLIF). Current price: 0.0161, daily change: $0.00 / 0.00%. Market cap: 2,053,858. Explore all performance metrics.
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.